First-in-Class Oral MK-6482 Shows Exciting Results in Clear-Cell Renal-Cell Carcinoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 110
- Publication type:
- Article
Works matching IS 21641153 AND DT 2020 AND VI 10 AND IP 2
Results: 16
1
2
GENITOURINARY CANCERS SYMPOSIUM: Sitravatinib, Novel TKI, plus Nivolumab Elicits Good Responses in Renal-Cell Carcinoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 109
- Publication type:
- Article
3
Atezolizumab-Bevacizumab Combo Improves Survival and Quality of Life in Unresectable Liver Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 108
- Publication type:
- Article
4
Encorafenib plus Cetuximab Improves Quality of Life versus Standard of Care in Colorectal Cancer Associated with BRAF Mutation.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 107
- Publication type:
- Article
5
GASTROINTESTINAL CANCERS SYMPOSIUM: Gemcitabine-Cisplatin Combination a New Standard in Pancreatic Cancer with Germline BRCA or PALB2 Mutation.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 106
- Publication type:
- Article
6
Unintended Consequences of COVID-19 on Oncology.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 105
- By:
- Publication type:
- Article
7
Oncology Pharmacy Making Adjustments.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 104
- By:
- Publication type:
- Article
8
Pharmaceutical Manufacturers’ Response to COVID-19.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 104
- By:
- Publication type:
- Article
9
Comprehensive Cancer Care Systems.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 103
- By:
- Publication type:
- Article
10
Washington and Public Policy: The COVID-19 Pandemic.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 102
- By:
- Publication type:
- Article
11
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 99
- By:
- Publication type:
- Article
12
Prevention of Chemotherapy-Induced Nausea and Vomiting in Adult Patients Undergoing Hematopoietic Stem-Cell Transplant: Is Olanzapine an Option?
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 94
- By:
- Publication type:
- Article
13
Rapid Onset of Severe Transaminitis in a Patient with Non–Small-Cell Lung Cancer After First Dose of Nivolumab 480 mg.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 83
- By:
- Publication type:
- Article
14
Reduction in Utilization and Costs Associated with Formulary Restrictions of Injectable Calcitonin.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 79
- By:
- Publication type:
- Article
15
Extended versus Intermittent Infusions of Piperacillin-Tazobactam in Patients with Febrile Neutropenia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 73
- By:
- Publication type:
- Article
16
Clinical Outcomes Using Carboplatin Desensitizations in Patients with Gynecologic Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 2, p. 65
- By:
- Publication type:
- Article